CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.230
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
2.270
+0.040 (1.79%)
After-hours: Dec 20, 2024, 7:05 PM EST
CervoMed Stock Forecast
CRVO's stock price has decreased by -69.24% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CervoMed stock have an average target of 38.75, with a low estimate of 12 and a high estimate of 63. The average target predicts an increase of 1,637.67% from the current stock price of 2.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CervoMed stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 5 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 → $12 | Strong Buy | Maintains | $65 → $12 | +438.12% | Dec 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
Financial Forecast
Revenue This Year
9.59M
from 7.14M
Increased by 34.17%
Revenue Next Year
6.12M
from 9.59M
Decreased by -36.16%
EPS This Year
-1.82
from -0.82
EPS Next Year
-1.45
from -1.82
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 13.0M | 12.5M | n/a | |||
| Avg | 9.6M | 6.1M | n/a | |||
| Low | 7.9M | 1.4M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 82.2% | 30.3% | - | |||
| Avg | 34.2% | -36.2% | - | |||
| Low | 11.1% | -85.7% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.38 | -0.08 | -1.33 | |||
| Avg | -1.82 | -1.45 | -2.23 | |||
| Low | -2.08 | -2.46 | -2.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.